| Name | Title | Contact Details |
|---|
Oasis For Orphans (o4o.org) is a non-profit organization dedicated to giving children in Kenya hope for a bright future. We believe that education is the key to unlocking opportunities, but when physical and educational needs are not met, the future be...
Campaign for Better Health Care is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthplus of Michigan is a Flint, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Generation after generation, families have depended upon Silver Cross Hospital to care for their loved ones. The commitment goes back to Thanksgiving Day in 1895 when the Will County Union of King`s Daughters and Sons opened the doors of a 33-bed hospital in Joliet named after their emblem the Maltese cross. Their promise was to provide quality healthcare with compassion for the citizens of Will County and surrounding communities. Today, more than a century later, Silver Cross Hospital remains true to that original promise. As the needs of the community grew, so did Silver Cross—in size and stature. Services rapidly expanded, evolved and increased in complexity. The medical staff advanced superior healthcare and attracted new expertise including specialists with Ann & Robert H. Lurie Children`s Hospital of Chicago, The Rehabilitation Institute of Chicago (RIC), University of Chicago Medicine Comprehensive Cancer Center, Northwestern Medicine for neurosciences and stroke care, and the Midwest Institute for Robotic Surgery. Silver Cross performs more robotic-assisted procedures than any other facility in the Chicago area. Surgeons from around the world come train with us. National prominence was achieved when Silver Cross- an independent healthcare provider, was first recognized as one of the nation`s 100 Top Hospitals in 2004—an accomplishment that has been repeated for seven years. And year after year, Silver Cross has been acknowledged as one of American`s Friendliest Hospitals because we treat patients the way they should be treated and for our dedication to patient safety with an “A” Hospital Safety Score from the Leapfrog Group. The mission of providing quality healthcare continues today with a remarkable 296-bed replacement hospital, which opened in 2012. All patient rooms are private—accommodating today`s medical technology and ultimately reducing unnecessary transfers and the risk of infection and injury. The hospital`s unique design creates efficiencies between departments and promotes an environment that helps patients heal faster. Our 158-acre New Lenox campus includes three medical/office buildings, University of Chicago Medicine Comprehensive Cancer Center, and an ambulatory care center opening in fall 2017. The hospital also has plans to build a 100-bed Behavioral Health Hospital to open in 2019. Over the years, Silver Cross has developed an extensive ambulatory network throughout the region that includes five satellite facilities with the independent services of many physicians and an array of outpatient services such as diagnostic imaging and rehabilitation. Silver Cross also operates a 27/7 freestanding Emergency Care Center in Homer Glen and an Urgent Care center in Joliet.
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.